Praluent is a prescription drug used for certain conditions, including high cholesterol. Find out about possible interactions ...

Lowering levels of 'bad' cholesterol is a well-established approach to reduce the risk of cardiovascular disease (CVD), but a significant need remains for drugs that could help achieve this goal.

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

A twice-a-year injection that reduces bad cholesterol to protect the heart ... each year for every 300,000 patients treated. The drug is not yet a licensed medicine, but a deal between the NHS ...

AstraZeneca has bought rights to an orally-active drug that inhibits PCSK9, offering a patient-friendly alternative to current cholesterol ... require subcutaneous injection every two to four ...

We are excited to make this new cholesterol-lowering medication available for patients in Europe." The drug is given in the form of a subcutaneous injection, either 140 mg every two weeks or 420mg ...

a decision is made whether to prescribe cholesterol-lowering medications. The most common are statins, which block an enzyme ...

If you're someone with high cholesterol, it's possible that your medications may be a contributing factor. Diuretics, ...

An expensive but "game-changing" anti-cholesterol drug could soon be offered to hundreds ... NHS England says inclisiran, given as a twice-a-year injection, could save about 30,000 lives within ...